Exchange: NASDAQ·Updated 01:21 PM EDT
LITS logo

LITS Lite Strategy, Inc.

$1.09
$0.052
(5.00%)
Today
EarningsSep 28
Mkt Cap$35.39M
Vol106,692.00

About LITS

Lite Strategy, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
67

Bullish Sentiment

How do you feel about LITS?

Advertisement|Remove ads.